Effects of KDT501 on Metabolic Features in Insulin Resistant Subjects
Clinical trial NCT02444910 · COMPLETED
Trial details
- NCT number
- NCT02444910
- Sponsor
- KinDex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-11-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.